XML 24 R13.htm IDEA: XBRL DOCUMENT v3.25.2

Inventories

6 Months Ended

Jun. 30, 2025

Inventory Disclosure [Abstract]

Inventories

Inventories

Inventories consisted of:

($ in millions)			June 30, 2025						December 31, 2024
Finished goods			$	2,142					$	2,022
Raw materials and work in process			9,888						8,831
Supplies			312						289
Total			12,342						11,142
Decrease to LIFO cost			(859)						(840)
			$	11,483					$	10,302
Recognized as:
Inventories			$	6,601					$	6,109
Other Assets			4,882						4,193

Amounts recognized as Other Assets are comprised almost entirely of raw materials and work in process inventories. At June 30, 2025 and December 31, 2024, these amounts included $4.3 billion and $3.8 billion, respectively, of inventories not expected to be sold within one year. In addition, these amounts included $572 million and $412 million at June 30, 2025 and December 31, 2024, respectively, of inventories produced in preparation for product launches (primarily MK-3475A, subcutaneous pembrolizumab).

X

- References

No definition available.

+ Details

Name:	us-gaap_InventoryDisclosureAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 330
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/330/tableOfContent

+ Details

Name:	us-gaap_InventoryDisclosureTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration